New Key Statistics Module, Z-Score and F-Score
NAS:VIR Key Ratios
Market Cap $ M | 1,062.71 |
Enterprise Value $ M | -323.01 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 0.67 |
Price/Sales | 26.35 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 39.00 |
EPS (TTM) $ | -4.59 |
Beneish M-Score | -9.64 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -179.60 |
EV-to-EBIT | 0.48 |
EV-to-EBITDA | 0.49 |
PEG | -- |
Shares Outstanding M | 135.03 |
Net Margin (%) | -1,557.35 |
Operating Margin % | -1,732.68 |
Pre-tax Margin (%) | -1,590.61 |
Quick Ratio | 9.05 |
Current Ratio | 9.05 |
ROA % (ttm) | -26.34 |
ROE % (ttm) | -33.70 |
ROIC % (ttm) | -200.09 |
Dividend Yield % | -- |
Altman Z-Score | 1.69 |
Piotroski F-Score | 3.00 |
Positive ROA | N |
Positive CFROA | N |
Higher ROA y-y | N |
Cash flow > Earnings | N |
Lower Leverage y-y | N |
Higher Current Ratio y-y | Y |
Less Shares Outstanding y-y | Y |
Gross Margin Increase y-y | Y |
Higher Asset Turnover y-y | N |
VIR Number of Guru Trades
VIR Volume of Guru Trades
Gurus Latest Trades with NAS:VIR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VIR is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Vir Biotechnology Inc Insider Transactions
No Available Data
News about NAS:VIR
Total 0- 1